Cet ouvrage et des milliers d'autres font partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour les lire en ligne
En savoir plus

Partagez cette publication

Du même publieur

 
 The legally binding text is the original French version  TRANSPARENCY COMMITTEE  OPINION  19 October 2011   EXELON 1.5 mg, capsule 2 blisters of 14 capsules (CIP code: 347 468-4) 4 blisters of 14 capsules (CIP code: 347 469-0)  EXELON 3 mg, capsule 2 blisters of 14 capsules (CIP code: 347 471-5) 4 blisters of 14 capsules (CIP code: 347 472-1)  EXELON 4.5 mg, capsule 2 blisters of 14 capsules (CIP code: 347 474-4) 4 blisters of 14 capsules (CIP code: 347 585-0)  EXELON 6 mg, capsule 2 blisters of 14 capsules (CIP code: 347 587-3) 4 blisters of 14 capsules (CIP code: 347 589-6)  EXELON 2 mg/mL, oral solution 1 bottle of 50 ml with syringe dispenser (CIP code: 363 489-2)  EXELON 4.6 mg/24 h, transdermal patch 30 sachets of 1 patch (CIP code: 381 947-9)  EXELON 9.5 mg/24 h, transdermal patch 30 paper sachets of 1 patch (CIP code: 381 949-1)   Applicant : NOVARTIS PHARMA S.A.S.  rivastigmine (hydrogen tartrate for oral forms) ATC code: N06DA03  List I Medicines for restricted medical prescription:  Medicines requiring special monitoring during treatment -- Initial annual prescription reserved for specialist neurologists and psychiatrists, and specialists holding a diplôme d'études spécialisées complémentaires [diploma of further specialised studies] in geriatrics and specialists or general practitioners holding a qualification in gerontology.  Date of Marketing Authorisation and amendments (centralised procedure): 12 May 1998 (capsules), 2 June 1999 (oral solution), 30 June 2003, 28 February 2006 (extension of indication) and 17 September 2007 (transdermal patches).  
 
1/4
Un pour Un
Permettre à tous d'accéder à la lecture
Pour chaque accès à la bibliothèque, YouScribe donne un accès à une personne dans le besoin